Defiance Daily Target 2X Long Uranium ETF
URAX
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 234 West Florida Street Milwaukee NY United States of America 53204
- IPO Date
- May 23, 2024
- Similar Companies
- Business
- Defiance Daily Target 2X Long Uranium ETF (URA X) is an exchange-traded fund that seeks daily investment results, before fees and expenses, of two times (2X) the daily performance of the Sprott Uranium Miners & Producers Index (URNM). The fund provides leveraged exposure to the uranium mining and production sector through a portfolio of uranium miners, producers, and related companies; it employs swap agreements, futures contracts, and other financial instruments to achieve its 2X daily target. URAX primarily targets sophisticated investors seeking amplified returns from uranium market movements and operates exclusively in the United States financial markets. Launched in 2024 by Defiance ETFs, headquartered in New York, NY, the fund is issued and managed by Defiance ETFs, a provider of thematic and leveraged ETFs focused on commodities, technology, and sector-specific strategies. It serves institutional and retail investors interested in leveraged plays on nuclear energy demand, uranium supply dynamics, and clean energy transitions. In late 2025, Defiance ETFs announced expansions in its leveraged commodity lineup, including enhancements to URAX's liquidity provisions and integration with broader nuclear energy thematic offerings amid rising global uranium spot prices; no major acquisitions or name changes were reported for the fund itself during this period. The ETF continues to emphasize daily rebalancing to maintain its leverage objective, with geographic exposure tied to global uranium operations in Canada, Australia, Kazakhstan, and the United States.